1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics

Chronic Disease Analysis & Statistics

1-28 of 28 reports

Company Analysis: Sanofi

  • $ 3000
  • January 2021
  • 69 pages

PharmaVitae explores Sanofi’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Sanofi will see strong pharmaceutical revenue growth over the forecast period, ...

  • United States
  • Pharmaceutical
  • Respiratory Disease
  • Company research
  • Company
  • Pharmaceutical Revenue

Company Analysis: Novo Nordisk

  • $ 3000
  • January 2021
  • 64 pages

PharmaVitae explores Novo Nordisk’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Novo Nordisk continues to dominate the diabetes segment, but pricing ...

  • United States
  • Insulin
  • Diabetes
  • Company research
  • Company

Company Analysis: AstraZeneca

  • $ 3000
  • January 2021
  • 87 pages

PharmaVitae explores AstraZeneca’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – AstraZeneca is poised for continued growth, driven by its oncology portfolio ...

  • World
  • China
  • Lung Cancer
  • Prescription Drug
  • Company research
  • Company

Type 2 Diabetes - Pipeline Review, H2 2020

  • $ 2500
  • November 2020
  • 1251 pages

Type 2 Diabetes - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Pipeline Review, H2 2020, provides an overview of the Type 2 Diabetes ...

  • World
  • Type 2 Diabetes
  • Endocrine Disease
  • Company research
  • Company

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2020

  • $ 2500
  • November 2020
  • 733 pages

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes - Pipeline Review, H2 2020, provides an overview of ...

  • World
  • Type 1 Diabetes
  • Endocrine Disease
  • Company research
  • Company

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

  • $ 2500
  • November 2020
  • 816 pages

Systemic Lupus Erythematosus - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus - Pipeline Review, H2 2020, provides an overview ...

  • World
  • Musculoskeletal Disorder
  • Company research
  • Company

Asthma - Pipeline Review, H2 2020

  • $ 2000
  • October 2020
  • 811 pages

Asthma - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Pipeline Review, H2 2020, provides an overview of the Asthma (Respiratory) pipeline ...

  • World
  • Asthma
  • Therapy
  • Company research
  • Company

Stroke - Pipeline Review, H2 2020

  • $ 2000
  • October 2020
  • 773 pages

Stroke - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H2 2020, provides an overview of the Stroke (Cardiovascular) pipeline ...

  • World
  • Stroke
  • Cardiology
  • Company research
  • Company

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020

  • $ 2000
  • August 2020
  • 631 pages

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure - Pipeline Review, H2 2020, provides ...

  • World
  • Cardiovascular Disease
  • Heart Failure
  • Company research
  • Company
  • Alcohol Excessive Use

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • $ 2500
  • July 2020
  • 1191 pages

Rheumatoid Arthritis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H2 2020, provides an overview of the ...

  • World
  • Arthritis
  • Company research
  • Company

Serine/Threonine Protein Kinase A Raf - Pipeline Review, H1 2020

  • $ 3500
  • June 2020
  • 34 pages

Serine/Threonine Protein Kinase A Raf - Pipeline Review, H1 2020 Summary Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) pipeline Target constitutes ...

  • World
  • Oncology
  • Pharmaceutical
  • Company research
  • Company
  • Pharmaceutical Registrations

Hypertension - Pipeline Review, H1 2020

  • $ 2500
  • June 2020
  • 772 pages

Hypertension - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Pipeline Review, H1 2020, provides an overview of the Hypertension ( ...

  • World
  • Hypertension
  • Cardiology
  • Company research
  • Company

Type 2 Diabetes - Pipeline Review, H1 2020

  • $ 2500
  • May 2020
  • 1220 pages

Type 2 Diabetes - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes – Pipeline Review, H1 2020, provides an overview of the Type 2 ...

  • World
  • Type 2 Diabetes
  • Endocrine Disease
  • Company research
  • Company

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2020

  • $ 2500
  • May 2020
  • 672 pages

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes – Pipeline Review, H1 2020, provides an overview ...

  • World
  • Type 1 Diabetes
  • Endocrine Disease
  • Company research
  • Company

Systemic Lupus Erythematosus - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 717 pages

Systemic Lupus Erythematosus - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H1 2020, provides ...

  • World
  • Musculoskeletal Disorder
  • Company research
  • Company

Stroke - Pipeline Review, H1 2020

  • $ 2500
  • April 2020
  • 716 pages

Stroke - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H1 2020, provides an overview of the Stroke (Cardiovascular) pipeline ...

  • World
  • Stroke
  • Cardiology
  • Company research
  • Company

Asthma - Pipeline Review, H1 2020

  • $ 2500
  • April 2020
  • 758 pages

Asthma - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Pipeline Review, H1 2020, provides an overview of the Asthma (Respiratory) pipeline ...

  • World
  • Asthma
  • Therapy
  • Company research
  • Company

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 558 pages

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure - Pipeline Review, H1 2020, provides ...

  • World
  • Cardiovascular Disease
  • Heart Failure
  • Company research
  • Company
  • Alcohol Excessive Use

Rheumatoid Arthritis - Pipeline Review, H1 2020

  • $ 2500
  • January 2020
  • 1156 pages

Rheumatoid Arthritis - Pipeline Review, H1 2020 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H1 2020, provides an overview of the ...

  • World
  • Arthritis
  • Company research
  • Company

Hypertension - Pipeline Review, H2 2019

  • $ 2500
  • December 2019
  • 699 pages

Hypertension - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Pipeline Review, H2 2019, provides an overview of the Hypertension ( ...

  • World
  • Hypertension
  • Cardiology
  • Company research
  • Company

Neuropathic Pain - Pipeline Review, H2 2019

  • $ 2500
  • December 2019
  • 838 pages

Neuropathic Pain - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H2 2019, provides an overview of the Neuropathic ...

  • World
  • Chronic Pain
  • Neurology
  • Company research
  • Company

Immunodiagnostic Systems Holdings plc - Product Pipeline Analysis, 2021 Update

  • $ 750
  • August 2021
  • 39 pages

Summary Immunodiagnostic Systems Holdings Ltd (IDS) is an in-vitro diagnostic solution provider.The company develops, manufactures, and markets immunoassays and automated immunoanalyser technologies. It ...

  • APAC
  • Diagnostics
  • Infectious Disease
  • Annual report
  • Company
  • Direct Sales
  • Medical Devices Sales

Nevro Corp (NVRO) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • June 2021
  • 47 pages

Summary Nevro Corp (Nevro) is a medical device company, which strives to provide novel products that advance the quality of life for people suffering from chronic pain in trunks and limbs.The company has ...

  • World
  • North America
  • Chronic Pain
  • Clinical Trial
  • Investor presentation
  • Company
  • Drug Approval
  • Medical Devices Sales

Lantheus Medical Imaging Inc - Product Pipeline Analysis, 2020 Update

  • $ 750
  • October 2020
  • 33 pages

Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of ...

  • Massachusetts
  • Clinical Trial
  • Health Care Provider
  • Company research
  • Company
  • Diagnostic Imaging Density
  • Practising Physicians

Akers Biosciences Inc (AKER) - Product Pipeline Analysis, 2020 Update

  • $ 750
  • October 2020
  • 51 pages

Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products.The company provides clinical diagnostics, safety ...

  • United States
  • Heart Attack
  • Clinical Trial
  • Annual report
  • Company
  • Computer Expenditure
  • Employment Income

AtriCure Inc (ATRC) - Product Pipeline Analysis, 2020 Update

  • $ 750
  • July 2020
  • 39 pages

Summary AtriCure Inc (AtriCure) is a provider of medical devices for the treatment of atrial fibrillation (Afib) and related conditions.The company develops, manufacture and sale of cardiac surgical ablation ...

  • United States
  • Europe
  • Cardiovascular Disease
  • Clinical Trial
  • Investor presentation
  • Company
  • Drug Approval
  • Medical Devices Sales

Digital Diagnostics Inc. - Tech Innovator Profile

  • $ 350
  • August 2020
  • 11 pages

Digital Diagnostics Inc. - Tech Innovator Profile Summary Digital Diagnostics Inc, formerly known as IDx Technologies, Inc. (IDx) specializes in artificial intelligence (AI) - based diagnostics and ...

  • World
  • E-Healthcare
  • Type 2 Diabetes
  • Investor presentation
  • Company
  • Health Provider Density

Company Analysis: AbbVie, Pharma Intelligence

  • $ 10000
  • January 2021
  • 62 pages

PharmaVitae explores AbbVie’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Declines in AbbVie’s flagship product Humira due to biosimilar competition ...

  • United States
  • Leukemia
  • Biosimilar
  • Company research
  • Company


About 3400 reports

Download Unlimited Documents from Trusted Public Sources

View report >

chinook therapeutics Investor presentation

  • November 2021
  • 4 pages
  • China
  • East Asia
  • Renal Disease
  • Therapy
  • Investor presentation
  • Company

Teva Analyst report November 2021


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on